Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 80.1% to $5.80. Palisade Bio announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules.
Silo Pharma, Inc. (NASDAQ: SILO) gained 63.7% to $5.60 after the company announced study results of SPU-21 for arthritis. The company said SPU-21 is effective in controlling arthritis progression.
F-star Therapeutics, Inc. (NASDAQ: FSTX) shares gained 42.8% to $5.84. F-Star Therapeutics shares traded lower on Thursday after the Committee on Foreign Investment issued an interim order preventing the closing of the pending merger with Invox Pharma.
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) jumped 38% to $33.65. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
Charah Solutions, Inc. (NYSE: CHRA) gained 37.6% to $5.57. Charah Solutions reported receipt of notification letter from NYSE.
Embark Technology, Inc. (NASDAQ: EMBK) gained 33% to $3.4686.
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) jumped 27.3% to $1.77.
Allarity Therapeutics, Inc. (NASDAQ: ALLR) jumped 26.7% to $0.3679.
Concord Medical Services Holdings Limited (NYSE: CCM) gained 23.8% to $1.6599.
Mereo BioPharma Group plc (NASDAQ: MREO) surged 23.6% to $0.69.
9 Meters Biopharma, Inc. (NASDAQ: NMTR) gained 23% to $1.4450.
Frequency Therapeutics, Inc. (NASDAQ: FREQ) jumped 22.5% to $3.97.
Journey Medical Corporation (NASDAQ: DERM) surged 22% to $1.77. Journey Medical recently announced PK comparability data of DFD-29 and key updates on the progress of ...
Benzinga
Servotronics, Inc.